First Internationally Certified Plasma Collection Center in Czech Republic

Informations

• Publié par: plasma-protein-therapeutics-association-ppta
• Nombre de lectures: 13
• Langue: English

Extrait

First Internationally Certified Plasma Collection
Center in Czech Republic
PR Newswire
ANNAPOLIS, Maryland, June 18, 2012
- EUROPLASMA Demonstrates Continued Leadership
ANNAPOLIS, Maryland, June 18, 2012 /PRNewswire/ -- The Plasma Protein Therapeutics
Association (PPTA) is delighted to announce that Europlasma, s.r.o has achieved
International Quality Plasma Program (IQPP) certification for the Darcovske centrum
Chodov (DCCH) in Prague. This modern facility is the first Czech Republic center to
achieve such recognition.
"We are pleased to achieve IQPP certification. It is a mark of distinction and gives further
assurance to stakeholders and the public that safety and quality are of the utmost
importance to Europlasma Group," said CEO Rudolf Meixner.
People worldwide depend on life saving plasma protein therapies to treat conditions such
as hemophilia, immune disorders, other diseases or injuries. IQPP standards help ensure
the highest level of quality and safety of human source plasma.
Certification requires completing a rigorous inspection by an independent third party,
demonstrating compliance with nine voluntary IQPP standards relating to donor and
center management. These standards provide important assurances in addition to strict
regulations.
EUROPLASMA Group manages seven plasma centers in Austria, in addition to the
Prague facility. They have operated in Vienna since 1986 and Prague since 2009, shortly
after legislation authorized private plasma collection. All of the company's centers have
achieved and maintained certification.
Joshua Penrod, Vice President, PPTA Source said, "This is an important milestone of
European plasma collection. This achievement demonstrates EUROPLASMA's sustained
commitment to plasma quality and safety."
About the Plasma Protein Therapeutics Association
The Plasma Protein Therapeutics Association (PPTA) is a dynamic trade association that
represents a unique sector of the biologics and biotechnology industry. PPTA member
companies manufacture high-impact, high-value plasma protein therapies that make a
difference in patients' lives every day throughout the world.
PPTA and its members focus on patient access to plasma protein therapies. We work in
tandem with more than 20 patient advocacy organizations to ensure that patients who
infuse or inject these complex biologics have confidence in their safety and quality.
Additionally, PPTA works globally with consumer groups, policymakers, and other key
stakeholders on critical issues of patient access to care.
PPTA also administers standards programs, including the International Quality Plasma
Program (IQPP) and Quality Standards of Excellence, Assurance and Leadership
(QSEAL): the National Donor Deferral Registry (NDDR), and the Patient Notification
System (PNS). PPTA's devotes itself daily to providing value to its membership and
making contributions towards improving and saving lives.